F Grüne1, M Schrappe, J Basten, H M Wenchel, E Tual, H Stützer. 1. University Clinic of Cologne, Clinic for Anesthesiology and Operative Intensive Medicine and ZDE Quality Management, Lindenthal, D-50924, Cologne, Germany, Frank.Gruene@uni-koeln.de
Abstract
BACKGROUND: An observational prospective cohort study was carried out on complication rates and time kinetics of phlebitis caused by short peripheral intravenous catheters (PIVCs) in inpatients on 15 hospital wards in four hospitals in Cologne, Germany. PATIENTS AND METHODS: We observed 1,582 patients with 2,495 PIVCs daily using standardized questionnaires. Phlebitis was defined using modified Centers for Disease Control and Prevention (CDC) criteria. RESULTS: Average phlebitis rates were 27 per 100 patients and 104 per 1,000 catheter days. Median duration of PIVC was 2 days (25 percentile = 2 days; 75 percentile 3 days). Time kinetics (Kaplan-Meier) were linear. CONCLUSION: Linear time kinetics of PIVC phlebitis do not support CDC recommendations for an elective PIVC change after 72 hours, provided daily monitoring of the insertion site occurs.
BACKGROUND: An observational prospective cohort study was carried out on complication rates and time kinetics of phlebitis caused by short peripheral intravenous catheters (PIVCs) in inpatients on 15 hospital wards in four hospitals in Cologne, Germany. PATIENTS AND METHODS: We observed 1,582 patients with 2,495 PIVCs daily using standardized questionnaires. Phlebitis was defined using modified Centers for Disease Control and Prevention (CDC) criteria. RESULTS: Average phlebitis rates were 27 per 100 patients and 104 per 1,000 catheter days. Median duration of PIVC was 2 days (25 percentile = 2 days; 75 percentile 3 days). Time kinetics (Kaplan-Meier) were linear. CONCLUSION: Linear time kinetics of PIVC phlebitis do not support CDC recommendations for an elective PIVC change after 72 hours, provided daily monitoring of the insertion site occurs.
Authors: Daniel Junker; Fabian Steinkohl; Veronika Fritz; Jasmin Bektic; Theodoros Tokas; Friedrich Aigner; Thomas R W Herrmann; Michael Rieger; Udo Nagele Journal: World J Urol Date: 2018-08-04 Impact factor: 4.226
Authors: H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox Journal: J Hosp Infect Date: 2014-01 Impact factor: 3.926
Authors: Pedro Parreira; Ricardo Vicente; Rafael A Bernardes; Liliana B Sousa; Beatriz Serambeque; Paulo Costa; Luciene M Braga; Lisete Mónico; Anabela Salgueiro-Oliveira Journal: Heliyon Date: 2020-08-08
Authors: Frank Doesburg; Joya M Smit; Wolter Paans; Marisa Onrust; Maarten W Nijsten; Willem Dieperink Journal: PLoS One Date: 2019-03-13 Impact factor: 3.240